blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1385535

EP1385535 - MODIFIED FVII IN TREATMENT OF ARDS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.12.2005
Database last updated on 02.09.2024
Most recent event   Tooltip02.12.2005Application deemed to be withdrawnpublished on 18.01.2006  [2006/03]
Applicant(s)For all designated states
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd / DK
[N/P]
Former [2004/06]For all designated states
NOVO NORDISK A/S
Novo Allé
2880 Bagsvaerd / DK
Inventor(s)01 / EZBAN, Mirella
Abildgaardsgade 24
DK-2100 Copenhagen / DK
02 / IDELL, Steven
18948 Lakeshore Drive
Tyler, TX 75703 / US
03 / PIANTADOSI, Claude, A.
3808 Kildrummy Drive
Durham, NC 27705 / US
 [2004/06]
Application number, filing date02766609.801.05.2002
[2004/06]
WO2002DK00279
Priority number, dateDK2001000069202.05.2001         Original published format: DK 200100692
[2004/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02087605
Date:07.11.2002
Language:EN
[2002/45]
Type: A2 Application without search report 
No.:EP1385535
Date:04.02.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 07.11.2002 takes the place of the publication of the European patent application.
[2004/06]
Search report(s)International search report - published on:EP03.01.2003
ClassificationIPC:A61K38/36
[2004/06]
CPC:
A61K38/4846 (EP,US); A61K38/36 (KR); A61P1/00 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P13/12 (EP);
A61P29/00 (EP); A61P43/00 (EP); A61P5/38 (EP);
A61P7/02 (EP); A61P9/00 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/06]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:MODIFIZIERTES FVII BEI DER BEHANDLUNG VON ARDS[2004/06]
English:MODIFIED FVII IN TREATMENT OF ARDS[2004/06]
French:FACTEUR VII MODIFIE POUR LE TRAITEMENT DU SYNDROME DE DETRESSE RESPIRATOIRE AIGUE[2004/06]
Entry into regional phase02.12.2003National basic fee paid 
02.12.2003Designation fee(s) paid 
02.12.2003Examination fee paid 
Examination procedure25.11.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
02.12.2003Examination requested  [2004/06]
30.01.2004Despatch of a communication from the examining division (Time limit: M06)
16.11.2004Reply to a communication from the examining division
03.03.2005Despatch of a communication from the examining division (Time limit: M04)
14.07.2005Application deemed to be withdrawn, date of legal effect  [2006/03]
18.08.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/03]
Request for further processing for:16.11.2004Request for further processing filed
16.11.2004Full payment received (date of receipt of payment)
Request granted
29.11.2004Decision despatched
Fees paidRenewal fee
01.06.2004Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.05.200504   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9215686  (ZYMOGENETICS INC [US], et al) [A] 1-55 * the whole document *;
 [X]US5997864  (HART CHARLES E [US], et al) [X] 1-55 * column W *;
 [X]WO0110892  (GENENTECH INC [US]) [X] 1-55 * page 15, line 36 - page 16, line 5 *;
 [X]  - DEBRA LAUREN MILLER ET AL, "Competitive inhibition of factor VIIa attenuates lung injury and pro-inflammatory cytokine release after intratracheal lipopolysaccharide.", FASEB JOURNAL -421.5., (2001), vol. 15, no. 4, page A497, XP002902639 [X] 1-55 * the whole document *
 [PX]  - KAREN E WELTY-WOLF ET AL, "Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons.", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (200111), vol. 164, no. 10, pages 1988 - 1996, XP002902640 [PX] 1-55 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.